+924.9%
MRNA vs ZYBT
-37.3%
+962.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ZYBT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.5% | +0.7% | -7.3% | -6.5% |
| 7D | +8.4% | -3.5% | +11.9% | +8.4% |
| 30D | +28.8% | +24.3% | +4.5% | +28.8% |
| 3M | +329.2% | -41.5% | +370.7% | +328.4% |
| 6M | +416.9% | +58.6% | +358.3% | +440.4% |
| YTD | +718.8% | +20.0% | +698.8% | +774.0% |
| 1Y | +924.9% | -35.2% | +960.1% | +1,061.9% |
| All | +924.9% | -37.3% | +962.1% | +1,061.9% |
Cumulative growth
Daily Returns
Daily percentage return beside ZYBT.
Daily Out/Under-Performance
Portfolio return minus ZYBT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ZYBT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ZYBT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling